Alife Health Receives CE Mark for AI Embryo Selection Tool
Alife Health has received CE Mark certification under the European Medical Device Regulation for its AI-based embryo selection software, Embryo Predict, announced in a press release. The approval allows the company to offer the product to fertility clinics across the European Union.
Embryo Predict uses deep learning to analyze embryo images and generate an AI score ranking embryos by their likelihood of resulting in a clinical pregnancy. The platform integrates with existing laboratory infrastructure to standardize embryo grading and reduce variation between embryologists.
With regulatory clearance in place, Alife plans to begin deploying the software to selected IVF centers in Europe. The company said this expansion builds on its U.S. operations, where its clinical decision support platform is already in use through partnerships with leading fertility networks.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Deep Longevity to Launch Accrua Telehealth Platform in US
EUCLYD Raises More Than €200 Million for AI Inference Infrastructure
AI in Clinical Trials Market Forecast to Reach USD 7.32 Billion by 2034
MGI Tech Launches VisiOmics in Europe
ACROBiosystems Launches ACRO AIx and Rapid Antibody Validation Service
Daily AI Brief: the AI news that matters, in your inbox.